Health
US FDA grants standard approval of Eisai/Biogen…
By Deena Beasley and Julie Steenhuysen LOS ANGELES (Reuters) -Eisai and Biogen's Leqembi won a…
US wants coalition of nations to engage China in…
By Michael Martina and Simon Lewis WASHINGTON (Reuters) - The U.S. wants other countries to engage…
Novartis buys Chinook for $3.5 billion in race to treat…
By Ludwig Burger (Reuters) -Novartis said it has agreed to acquire U.S. biotech firm Chinook…
Novartis’ Sandoz wagers its standalone future on…
By Natalie Grover LONDON (Reuters) - Novartis' soon-to-be spun off generics division Sandoz is…
Roche looking to sell or shut down California biologic…
(This May 31 story has been corrected to fix the spelling of executive's name to Teresa, not…
AstraZeneca’s Tagrisso slashes death risk in…
By Natalie Grover LONDON (Reuters) - AstraZeneca's lung cancer therapy, Tagrisso, cut the risk…
Medtronic’s profit forecast hit by stronger…
By Bhanvi Satija and Raghav Mahobe (Reuters) -Medtronic Plc on Thursday forecast annual profit…
